Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) as a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 19 Dec 2018
At a glance
- Drugs Melphalan (Primary) ; Filgrastim; Palifermin
- Indications Multiple myeloma
- Focus Adverse reactions
- 11 Dec 2018 Planned initiation date changed from 1 Nov 2018 to 1 Feb 2019.
- 11 Sep 2018 Planned End Date changed from 1 Aug 2021 to 1 Aug 2020.
- 11 Sep 2018 Planned initiation date changed from 1 Aug 2018 to 1 Nov 2018.